UK could lose out on Europe-wide drug safety system post-Brexit

12-02-2019

UK could lose out on Europe-wide drug safety system post-Brexit

angelsolergollonet / Shutterstock.com

UK patients could be more exposed to counterfeit medicines than EU patients in the event of a ‘no deal’ Brexit, because access to an initiative aimed at protecting patients from fake drugs could be lost.


fake medicines, medicines supply chain, counterfeit drugs, Brexit, Falsified Medicines Directive, ABPI

LSIPR